PRRT2 and cancer: CHE imparted anticancer effects on HCC827 by inhibiting PKC and caspase-3 activation, which were blocked by PMA, a PKC activator, thereby proving that CHE inhibited cancer cell viability and proliferation and induced cell apoptosis through the ROS/PKC-ε/caspase three pathway and glycolysis (Wang et al., 2021).